Objective: The objective of this study was to evaluate and correlate hematologic indices, vitamin B12 levels, and depression in patients with suspected laryngopharyngeal reflux (LPR) treated with proton pump inhibitor (PPI).
Methods: This was a prospective study with a population (n = 23) consisted of patients with suspected LPR and treated with 2 daily doses of Omeprazole 40 mg (80 mg or full dose). The study volunteers performed a complete blood count and vitamin B12 dosage before and after 3 and 6 months of treatment, as well as depression screening using the Center of Epidemiologic Studies-Depression (CES-D) questionnaire before and after 6 months of treatment. Scores greater than 16 were considered as suggestive of depression.
Results: The mean score on the CES-D scale of study participants at baseline significantly decreased after 6 months of treatment. A significant decrease was observed in the red blood cells count (RBC) after 6 months in relation to 3 months. Significant increases in mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) were observed from 3 months to 6 months in this study. Vitamin B12 levels increased significantly between baseline and after 6 months of treatment.
Conclusion: Decreased scores on the CES-D scale were associated with increased MCV values, with no association with vitamin B12 levels. However, vitamin B12 levels also increased significantly after 6 months of treatment with PPI.
Keywords: B12 vitamin; Laryngopharyngeal reflux; blood count; depression; proton pump inhibitor.
Conflict of interest statement
Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Predictors of Response to Short-Term Proton Pump Inhibitor Treatment in Laryngopharyngeal Reflux PatientsN Siupsinskiene et al. J Laryngol Otol 122 (11), 1206-12. PMID 18331659.Three months of proton pump inhibitor treatment twice daily is warranted for confirming suspicion of laryngopharyngeal reflux. Baseline anxiety levels and heartburn score …
Influence of Age on Treatment With Proton Pump Inhibitors in Patients With Laryngopharyngeal Reflux Disease: A Prospective Multicenter StudyYC Lee et al. JAMA Otolaryngol Head Neck Surg 139 (12), 1291-5. PMID 24201320.In patients with LPR, age seems to affect the subjective symptoms and resulting impact on quality of life but not the laryngeal findings. Furthermore, older patients are …
Laryngopharyngeal Reflux: Prospective Cohort Study Evaluating Optimal Dose of Proton-Pump Inhibitor Therapy and Pretherapy Predictors of ResponseW Park et al. Laryngoscope 115 (7), 1230-8. PMID 15995512.BID PPI appears to be more effective than QD PPI in achieving clinical symptom response in suspected LPR. More response was achieved at 4 months compared with 2 months. T …
Evaluation and Management of Laryngopharyngeal RefluxCN Ford. JAMA 294 (12), 1534-40. PMID 16189367. - ReviewLaryngopharyngeal reflux should be suspected when the history and laryngoscopy findings are suggestive of the diagnosis. Failure to respond to a 3-month trial of behavior …
A Meta-Analysis for the Role of Proton Pump Inhibitor Therapy in Patients With Laryngopharyngeal RefluxC Wei. Eur Arch Otorhinolaryngol 273 (11), 3795-3801. PMID 27312992. - ReviewWe aimed to systematically review the randomized controlled trials (RCTs) regarding the therapeutic efficiency of proton pump inhibitor (PPI) therapy for laryngopharyngea …
- Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA. 2005;294:1534–1540. - PubMed
- Abou-Ismail A, Vaezi MF. Evaluation of patients with suspected laryngopharyngeal reflux: a practical approach. Curr Gastroenterol Rep. 2011;13:213–218. - PubMed
- Vaezi MF. Laryngitis: from the gastroenterologist’s point of view. In: Vaezi MF, editor. ed. Extraesophageal Reflux. San Diego, CA: Plural; 2009:37–47.
- Sataloff RT, Hawkshaw MJ, Gupta R. Laryngopharyngeal reflux and voice disorders: an overview on disease mechanisms, treatments, and research advances. Discov Med. 2010;10:213–224. - PubMed
- IMS Health. A review of the use of medicines in the United States in 2012. www.imshealth.com/deployedfiles/ims/Global/Content/Insights/IM2013.